Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole

被引:24
|
作者
Ochoa, Dolores [1 ,2 ]
Roman, Manuel [1 ,2 ]
Cabaleiro, Teresa [1 ,2 ]
Saiz-Rodriguez, Miriam [1 ,3 ]
Mejia, Gina [1 ,2 ]
Abad-Santos, Francisco [1 ,2 ,4 ]
机构
[1] Univ Autonoma Madrid UAM, Inst Invest Sanitaria La Princesa IP, Inst Teofilo Hernando, Clin Pharmacol Dept,Hosp Univ La Princesa, C Diego de Leon 62, Madrid 28006, Spain
[2] Inst Invest Sanitaria La Princesa IP, UICEC Hosp Univ La Princesa, Plataforma SCReN Spanish Clin Reseach Network, Madrid, Spain
[3] Hosp Univ Burgos, Fdn Burgos Invest Salud, Res Unit, Burgos, Spain
[4] Univ Autonoma Madrid, Fac Med, Pharmacol Dept, Madrid, Spain
来源
BMC PHARMACOLOGY & TOXICOLOGY | 2020年 / 21卷 / 01期
关键词
Proton pump inhibitors; Food; Pharmacokinetics; Omeprazole; Rabeprazole; Pantoprazole; PROTON PUMP INHIBITOR; ESOMEPRAZOLE; CAPSULE; ARTICLE;
D O I
10.1186/s40360-020-00433-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background The pharmacokinetics of proton pump inhibitors (PPIs) may be affected by food intake. We aimed to evaluate the effect of food on the pharmacokinetics of omeprazole, rabeprazole, and pantoprazole. Setting The study population comprised 186 healthy volunteers participating in 6 bioequivalence clinical trials. Method Subjects were evaluated to determine the effect of a high-fat breakfast on the pharmacokinetics of omeprazole (n = 36), rabeprazole (n = 69), and pantoprazole (n = 81). Main outcome measure Drug plasma concentrations were measured using high-performance liquid chromatography coupled to mass spectrometry. Results Food affected the pharmacokinetics of omeprazole (increased T(max)and decreased AUC and C-max), pantoprazole (increased T(max)and decreased AUC), and rabeprazole (increased T-max, C(max)and half-life). Food increased variability in T(max)for all 3 drugs, delaying absorption around 3 to 4 h and until 20 h in some subjects. Conclusion As food delays the absorption of PPIs and increases their variability, it would be better to administer these drugs under fasting conditions.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
    Dolores Ochoa
    Manuel Román
    Teresa Cabaleiro
    Miriam Saiz-Rodríguez
    Gina Mejía
    Francisco Abad-Santos
    BMC Pharmacology and Toxicology, 21
  • [2] Evaluation of the relationship between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
    Roman, Manuel
    Ochoa, Dolores
    Daniel Sanchez-Rojas, Sergio
    Talegon, Maria
    Prieto-Perez, Rocio
    Rivas, Angela
    Abad-Santos, Francisco
    Cabaleiro, Teresa
    PHARMACOGENOMICS, 2014, 15 (15) : 1893 - 1901
  • [3] Pharmacokinetics and effect an caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole
    Andersson, T
    Holmberg, J
    Röhss, K
    Walan, A
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (04) : 369 - 375
  • [4] Improved HPLC Method for Determination of Four PPIs, Omeprazole, Pantoprazole, Lansoprazole and Rabeprazole in Human Plasma
    Noubarani, Maryam
    Keyhanfar, Fariborz
    Motevalian, Manijeh
    Mahmoudian, Masoud
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2010, 13 (01): : 1 - 10
  • [5] Pharmacokinetics of Rabeprazole Granules Versus Tablets, and the Effect of Food on the Pharmacokinetics of Rabeprazole Granules in Healthy Adults-Cross-Study Comparison
    Thyssen, An
    Solanki, Bhavna
    Gonzalez, Martha
    Leitz, Gerhard
    Treem, William
    Mannaert, Erik
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (05): : 406 - 416
  • [7] THE EFFECT OF FOOD AND RABEPRAZOLE ON THE PLASMA PHARMACOKINETICS OF LORLATINIB IN HEALTHY SUBJECTS.
    Xu, H.
    O'Gorman, M. T.
    Nepal, S.
    Ginman, K.
    Bergeron, M. J.
    Lee, K. C.
    Fumagalli, L.
    da Costa, L. Mendes
    Pithavala, Y. K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S93 - S93
  • [8] The pharmacokinetics of pantoprazole and omeprazole in patients with erosive gastroesophageal reflux disease.
    Pratha, VS
    Karlstadt, RG
    Lynn, RB
    Burton, MS
    Hogan, DL
    PHARMACOTHERAPY, 2002, 22 (10): : 1364 - 1364
  • [9] Comparison of Antioxidant Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, and Rabeprazole
    Abed, Mohammed N.
    Alassaf, Fawaz A.
    Jasim, Mahmood H. M.
    Alfahad, Mohanad
    Qazzaz, Mohannad E.
    PHARMACOLOGY, 2020, 105 (11-12) : 645 - 651
  • [10] Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: A five-way crossover study
    Miner, P
    Katz, PO
    Chen, YS
    Sostek, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (12): : 2616 - 2620